Skip to main content
Download PDF

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Molecular Cancer volume 19, Article number: 93 (2020) Cite this article

The Original Article was published on 10 April 2019

Correction to: Mol Cancer (2019) 18:85

https://doi.org/10.1186/s12943-019-1012-4

Following the publication of the original article [1], the authors spotted error in Fig. 1C. The colony formation image of H1792 in control row was accidently placed the same image of H322. This is a mistake and has to be corrected. Now, the actual image of H1792 in control row is placed at H1792 spot in revised Fig. 1 (below). This correction does not change any conclusions made in the article. The authors apologize for this error and any confusion it may have caused.

figure a

Reference

  1. Xu K, Park D, Magis AT, Zhang J, Zhou W, Sica GL, Ramalingam SS, Curran WJ, Deng X. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy. Mol Cancer. 2019;18:85 https://doi.org/10.1186/s12943-019-1012-4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA

    Ke Xu, Dongkyoo Park, Walter J. Curran & Xingming Deng

  2. Institute for Systems Biology, Seattle, WA, 98109, USA

    Andrew T. Magis

  3. Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA

    Jun Zhang

  4. Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA

    Wei Zhou & Suresh S. Ramalingam

  5. Department of Pathology and Laboratory Medicine, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA

    Gabriel L. Sica

Authors
  1. Ke Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dongkyoo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew T. Magis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gabriel L. Sica
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Suresh S. Ramalingam
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Walter J. Curran
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xingming Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xingming Deng.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, K., Park, D., Magis, A.T. et al. Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy. Mol Cancer 19, 93 (2020). https://doi.org/10.1186/s12943-020-01214-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-020-01214-5

Molecular Cancer

ISSN: 1476-4598